i just took my first dose of semaglutide 🎉 Week 1 on Ozempic [My & Why I’m Starting This Journey] How Many mg Is 40

Approval Timeline and Availability CagriSema: Ahead in the Race FDA Submission: December 18, 2025 (NDA filed) Expected FDA Decision: Q4 2026 or Q1 2027 Predicted Launch: Mid-2027 Advantage: 6-12 month head start on retatrutide REDEFINE Program Status: REDEFINE-1: Completed (obesity, 20.4% weight loss) REDEFINE-2: Completed (type 2 diabetes, 13.7% weight loss) REDEFINE-3: Ongoing (cardiovascular outcomes trial) REDEFINE-8: Ongoing (body composition study) High-dose CagriSema (2.4/7.2mg): Starting late 2026 Retatrutide: More Trials Needed FDA Submission: Expected Q4 2026 or Q1 2027 Expected FDA Decision: Late 2027 Predicted Launch: Q1-Q2 2028 TRIUMPH Program Status: TRIUMPH-4: Completed (osteoarthritis, 28.7% weight loss) TRIUMPH-1: Complete 28.3% weight loss (May 2026) TRIUMPH-2: Expected Q3Q4 2026 (obesity + type 2 diabetes) TRIUMPH-3: Expected later 2026 (obesity + cardiovascular disease) TRIUMPH-6: Weight maintenance trial (ongoing) Disadvantage: Needs more trials before submission, 6-12 month delay vs CagriSema

Never shake the vial after reconstitution

Visceral adiposity reduction: Rapid visceral fat decline could benefit patients with metabolic syndrome beyond glycemic disorders

Ceramide regulates cellular homeostasis via diverse stress signaling pathways

If youre considering online weight loss prescriptions but unsure about the process, safety, or legitimacy, understanding how telehealth works for GLP-1 medications helps you access effective treatment conveniently while ensuring proper medical oversight

Retatrutide is widely studied as a triple receptor agonist, engaging GLP-1, GIP, and glucagon pathways linked to metabolic regulation, appetite signalling, energy balance, glucose metabolism, lipid utilisation, and body composition research